학술논문

Tisotumab Vedotin in Combination with Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 Study
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 December 2023, 41(36):5536-5549)
Subject
Language
English
ISSN
15277755
0732183X